Omadacycline receives Qualified Infectious Disease Product designation from FDA
Paratek announced its investigational antibiotic omadacycline has been granted an additional Qualified Infectious Disease Product designation by the FDA for treatment of uncomplicated urinary tract infections for both the oral and the intravenous formulations. September 21, 2017